Accomplished Healthcare, Nonprofit and Public Affairs Executive to Advance Countdown’s Mission to Accelerate Mitochondrial Science and Medicine Countdown Chief Executive Officer Julie Teer, Countdown CEO ATLANTA, Aug. 18, 2026 (GLOBE NEWSWIRE) — Countdown, the global nonprofit accelerating mitochondrial science and
Funding supports pioneering research to evaluate a novel approach designed to restore cellular energy and preserve muscle function, laying the foundation for a new generation of therapies across rare disease, chronic disease, and aging Dr. James McCully, Associate Professor of
ATLANTA, May 15, 2026 (GLOBE NEWSWIRE) — Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr. Elias Adriaenssens at the Research Institute of Molecular Pathology (IMP)
ATLANTA, May 15, 2026 (GLOBE NEWSWIRE) — Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr. Elias Adriaenssens at the Research Institute of Molecular Pathology (IMP)
Raising funds to advance high-impact mitochondrial research with applications across rare disease, neurodegeneration, and healthspan A Media Snippet accompanying this announcement is available by clicking on this link. ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) — Countdown For A Cure (CFAC)
Raising funds to advance high-impact mitochondrial research with applications across rare disease, neurodegeneration, and healthspan A Media Snippet accompanying this announcement is available by clicking on this link. ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) — Countdown For A Cure (CFAC)
